Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19

Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19

El síndrome respiratorio agudo severo coronavirus 2 (SARS-CoV-2) es responsable de la enfermedad denominada COVID-19 (acrónimo del inglés Coronavirus Disease-2019). Esta enfermedad fue detectada inicialmente en la ciudad de Wuhan, China en diciembre de 2019. Las personas contagiadas con COVID-19 pre...

Full description

Bibliographic Details
Main Author:	Norma Francenia Santos-Sánchez
Format:	Article
Language:	English
Published:	Medwave Estudios Limitada 2020-09-01
Series:	Medwave
Subjects:	betacoronavirus mechanism of action sars-cov-2 sars-cov-2 testing transmission antiviral agents
Online Access:	https://www.medwave.cl/link.cgi/Medwave/Revisiones/RevisionClinica/8037.act

Similar Items

Proof-of-concept for effective antiviral activity of an in silico designed decoy synthetic mRNA against SARS-CoV-2 in the Vero E6 cell-based infection model
by: Nofar Atari, et al.
Published: (2023-04-01)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel, et al.
Published: (2020-03-01)

Recomendaciones de la Asociación Colombiana de Nefrología en casos de trasplante renal durante la pandemia por COVID-19
by: Rodolfo Torres Serrano, et al.
Published: (2020-04-01)

Pandemia da COVID-19: o maior desafio do século XXI
by: Sávio Breno Pires Brito, et al.
Published: (2020-04-01)

Pandemia da COVID-19: o maior desafio do século XXI
by: Sávio Breno Pires Brito, et al.
Published: (2020-04-01)

Pandemia da COVID-19: o maior desafio do século XXI
by: Sávio Breno Pires Brito, et al.
Published: (2020-04-01)

<i>Betacoronavirus</i> Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
by: Alejandro Llanes, et al.
Published: (2020-06-01)

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
by: Jennifer K. DeMarco, et al.
Published: (2021-11-01)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: Matheus Oliveira de Souza, et al.
Published: (2022-09-01)

The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
by: Lo’ai Alanagreh, et al.
Published: (2020-04-01)

Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus)
by: Dmitry K. Lvov, et al.
Published: (2020-05-01)

Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention
by: Nikola Gligorijevic, et al.
Published: (2021-11-01)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
by: João Trigueiro-Louro, et al.
Published: (2020-01-01)

An overview on the treatments and prevention against COVID-19
by: Yunes Panahi, et al.
Published: (2023-02-01)

The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
by: Nicholas A. Wong, et al.
Published: (2021-01-01)

SARS-CoV-2: estructura, replicación y mecanismos fisiopatológicos relacionados con COVID-19
by: Gabriela Antezana Llaveta, et al.
Published: (2020-12-01)

Acute pancreatitis and COVID-19: a new target for infection?
by: Júlia Aith Balthazar, et al.
Published: (2022-02-01)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
by: Clarisse Salgado-Benvindo, et al.
Published: (2023-06-01)

Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress
by: Angelina Kovalenko, et al.
Published: (2023-01-01)

Efficacy of Favipiravir in the Treatment of Moderate COVID-19 Patients: A Randomized, Open-label, Controlled Clinical Trial
by: Shabnam TEHRANI, et al.
Published: (2022-08-01)

COVID-19 coronavirus: pathogenesis, clinical features, diagnostics, epidemiology, prevention and control
by: Yousra El-Maradny, et al.
Published: (2020-06-01)

Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
by: Ramesh K. Goyal, Jaseela Majeed, Rajiv Tonk, Mahaveer Dhobi, Bhoomika Patel, Kalicharan Sharma, Subbu Apparsundaram
Published: (2020-09-01)

COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
by: Chow Suet-May, et al.
Published: (2022-12-01)

Effectiveness of Antiviral Drugs as Covid-19 Therapy
by: Adelia Firandi, et al.
Published: (2021-06-01)

Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa
by: Susan Engelbrecht, et al.
Published: (2021-03-01)

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
by: Victoria Callahan, et al.
Published: (2021-06-01)

A Dual Role of Complement Activation in the Development of Fulminant Hepatic Failure Induced by Murine-Beta-Coronavirus Infection
by: Yingying Fang, et al.
Published: (2022-04-01)

Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?
by: Francesco Petrillo, et al.
Published: (2021-07-01)

Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics
by: Reed L. Berkowitz, et al.
Published: (2023-10-01)

A Review of Candidate Therapies for Beta Coronavirus a Molecular Research
by: Fatema Bassam Ahmed, et al.
Published: (2021-10-01)

GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events
by: Viktoria Zaderer, et al.
Published: (2023-03-01)

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
by: Varghese Edwin Hillary, et al.
Published: (2023-03-01)

On the Origin and Propagation of the COVID-19 Outbreak in the Italian Province of Trento, a Tourist Region of Northern Italy
by: Luca Bianco, et al.
Published: (2022-03-01)

Effectiveness of wearing masks during the COVID-19 outbreak in cohort and case-control studies: a systematic review and meta-analysis
by: Idevaldo Floriano, et al.
Published: (2024-01-01)

In vitro antiviral effect of silver nanoparticles against SARS-CoV-2
by: Lizdany Flórez-Álvarez, et al.
Published: (2023-01-01)

Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
by: Jerneja Kladnik, et al.
Published: (2022-12-01)

Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials
by: Chih-Cheng Lai, et al.
Published: (2021-10-01)

JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
by: Juhee Son, et al.
Published: (2022-02-01)

Sars-Cov-2 And Betacoronavirus: What Have We Learned In 8 Months?
by: Kwiatek Agnieszka, et al.
Published: (2020-01-01)

Indian Herb-Derived Phytoconstituent-Based Antiviral, Antimicrobial and Antifungal Formulation: An Oral Rinse Candidate for Oral Hygiene and the Potential Prevention of COVID-19 Outbreaks
by: Shashwat Sharad, et al.
Published: (2021-09-01)